Skip to main content
Log in

Activity of the fourth generation cephalosporin FK-037 against methicillin-resistantStaphylococcus aureus under conditions maximizing PBP2′ production

  • New Antimicrobial Agent
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

To investigate the in vitro activity of the fourth generation cephalosporin FK-037, MICs were determined for 80 strains of methicillin-resistantStaphylococcus aureus from 11 countries. Methicillin and cefamandole served as comparators. The method ensured good expression of PBP2′ by use of a large inoculum, salt supplement and incubation for 48 hours at 30°C. FK-037 was twice as active as cefamandole against both strains with high-level and strains with low-level methicillin resistance (geometric mean MICs 23.4 and 10.8 mg/l, respectively).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mine Y, Watanabe Y, Sakamoto H, Hatano K, Kuno K, Kamimura T, Tawara S, Matsumoto Y, Matsumoto F, Kuwahara S Excellent activity of FK-037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci. Journal of Antibiotics 1993, 46: 99–119.

    PubMed  Google Scholar 

  2. Fu KP, Foleno BD, Lafredo SC, LoCoco JM, Isaacson DM In vitro and in vivo antibacterial properties of FK-037, a novel parenteral broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy 1993, 37: 301–307.

    PubMed  Google Scholar 

  3. Neu HC, Chin NX, Huang HB In vitro activity and β-lactamase stability of FK-037, a parenteral cephalosporin. Antimicrobial Agents and Chemotherapy 1993, 37: 566–573.

    PubMed  Google Scholar 

  4. Washington JA, Jones RN, Gerlach EH, Murray PR, Allen SD, Knapp CC Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftaxidime, and cefuroxime. Antimicrobial Agents and Chemotherapy 1993, 37: 1696–1700.

    PubMed  Google Scholar 

  5. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing. Document M100-S4. NCCLS, Villanova, PA, 1992.

    Google Scholar 

  6. Yawata M Control of MRSA infections. Lancet 1993, 341: 483.

    Google Scholar 

  7. Milne LM, Crow MR, Emptage AGM, Selkon JB Effects of culture media on detection of methicillin resistance inStaphylococcus aureus and coagulase-negative staphylococci by disc diffusion methods. Journal of Clinical Pathology 1993, 46: 394–397.

    PubMed  Google Scholar 

  8. Hamilton-Miller JMT, Maple PAC Antibiogram typing of methicillin-resistantStaphylococcus aureus: a comparison with phage typing, biotyping and API Staph. Zentrallblatt für Bakteriologie 1993, 279: 214–224.

    Google Scholar 

  9. Brumfitt W, Hamilton-Miller JMT Methicillin-resistantStaphylococcus aureus. New England Journal of Medicine 1989, 320: 1188–1196.

    PubMed  Google Scholar 

  10. Ling JM, Lam AW, Cheng AF, French GL Activity of β-lactam antibiotics in an animal model against methicillin-resistantStaphylococcus aureus. Journal of Antimicrobial Chemotherapy 1993, 32: 919–920.

    PubMed  Google Scholar 

  11. Toyosawa T, Miyazaka S, Tsuji A, Yamaguchi K, Goto S In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin. Antimicrobial Agents and Chemotherapy 1993, 37: 60–66.

    PubMed  Google Scholar 

  12. Tanaka M, Otsuki M, Nishino T In vitro and in vivo activities of DQ-2556 and its mode of action. Antimicrobial Agents and Chemotherapy 1992, 36: 2595–2601.

    PubMed  Google Scholar 

  13. Iwahi T, Okonogi K, Yamazaki T, Shiki S, Kondo M, Miyake A, Imada A In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum. Antimicrobial Agents and Chemotherapy 1992, 36: 1358–1366.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamilton-Miller, J.M.T. Activity of the fourth generation cephalosporin FK-037 against methicillin-resistantStaphylococcus aureus under conditions maximizing PBP2′ production. Eur. J. Clin. Microbiol. Infect. Dis. 13, 1053–1055 (1994). https://doi.org/10.1007/BF02111826

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02111826

Keywords

Navigation